SI-BONE, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +16.8%
EBITDA: +68.1%
EBIT: +35.0%
EPS: +39.4%
Free cash flow: +72.6%
Operating cash flow: +119.2%

Forward estimates

Revenue: +21.2%
EBITDA: +1706.4%
EPS: -5.1%

Three-year CAGR

Revenue: +23.6%
EBITDA: +52.8%
EBIT: +36.6%
Net income: +38.8%
EPS: +41.3%
Free cash flow: +60.3%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.